-
Media Release
Novartis Scemblix® granted FDA Priority Review for the treatment of adults with newly diagnosed CML
-
Story
Giving voice to people with a misunderstood disease -
Story
Facing the fear of breast cancer recurrence -
Landing Page
My Cancer. My Words.
-
Story
Innovation fueled by compassion -
Story
Q&A: Addressing unmet needs for people living with PNH, a rare and chronic blood disorder -
Story
When you think of the word ‘cancer’, what are the first words that spring to mind? -
Story
Breaking down barriers for patients with sickle cell disease -
Story
Demystifying the science of myelodysplastic syndromes -
Media Release
Novartis signs new initial agreement with BioNTech to support fill and finish of the mRNA Pfizer-BioNTech COVID-19 vaccine
-
Media Release
Novartis Cosentyx® builds on its axSpA leadership with US label update for dosing flexibility in ankylosing spondylitis
-
Landing Page
Diseases